Label: ANTIBACTERIALTABLETS- chlorhexidine acetate tablet

  • NDC Code(s): 84260-005-01
  • Packager: Guangzhou Lvying Biotechnology Co., Ltd
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated May 16, 2024

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT

    CHLORHEXIDINE ACETATE

  • PURPOSE

    Antibacterial Tablets

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of Reach of Children.

  • INDICATIONS & USAGE

    Antibacteria lTablets

  • WARNINGS

    Keep Away form fire or Flame for External Use omly.

  • DOSAGE & ADMINISTRATION

    Wash your hands and private parts before use, place the tablets slowlydeep in the vagina for 40 minutes, and have intercourse after 5-7 hoursfor better results You can use 2 tablets for the first time and one tablet forthe next 2-3 days.

  • STORAGE AND HANDLING

    Away from direct sunlight and keep in cool place.
    Keep out of Reach of Children.
    Keep Away form fire or Flame for External Use omly.

  • INACTIVE INGREDIENT

    BLETILLA STRIATA EXTRACT
    CYNANCHUM OTOPHYLLUM EXTRACT
    ANGELICAE DAHURICAE RADIX EXTRACT
    CYPERI RHIZOMA EXTRACT
    SODIUM HYALURONATE

  • PRINCIPAL DISPLAY PANEL

    label5

  • INGREDIENTS AND APPEARANCE
    ANTIBACTERIALTABLETS 
    chlorhexidine acetate tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:84260-005
    Route of AdministrationVAGINAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CHLORHEXIDINE ACETATE (UNII: 5908ZUF22Y) (CHLORHEXIDINE - UNII:R4KO0DY52L) CHLORHEXIDINE ACETATE0.015 g
    Inactive Ingredients
    Ingredient NameStrength
    HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
    ANGELICA DAHURICA ROOT (UNII: 1V63N2S972)  
    CYPERUS ROTUNDUS TUBER (UNII: 4B51SRR959)  
    BLETILLA STRIATA WHOLE (UNII: WV2BSG60EW)  
    CYNANCHUM OTOPHYLLUM WHOLE (UNII: 02I89C6K47)  
    Product Characteristics
    ColorwhiteScorescore with uneven pieces
    ShapeOVALSize13mm
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:84260-005-018 in 1 BOX; Type 0: Not a Combination Product04/29/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph Drug505G(a)(3)04/29/2024
    Labeler - Guangzhou Lvying Biotechnology Co., Ltd (714445262)
    Establishment
    NameAddressID/FEIBusiness Operations
    Guangzhou Lvying Biotechnology Co., Ltd714445262manufacture(84260-005)